Factors associated with late hospice admission for cancer patients identified

This article originally appeared here.
Factors ID'd for Late Hospice Admission for Cancer Patients
Factors ID'd for Late Hospice Admission for Cancer Patients

(HealthDay News) -- For patients with cancer, factors associated with late admission to hospice have been identified, according to a study published online Aug. 25 in the Journal of Clinical Oncology.

Nina R. O'Connor, M.D., from the University of Pennsylvania, and colleagues evaluated electronic health records for patients with cancer admitted to 12 hospices in the Coalition of Hospices Organized to Investigate Comparative Effectiveness network. The authors examined patient characteristics associated with hospice enrollment in the last three days of life.

The researchers found that 16.3 percent of the 64,264 patients admitted to hospice with cancer had a length of stay of three days or less. The proportion of patients enrolled in the last three days of life varied considerably among hospices (range, 11.4 to 24.5 percent). In multivariable analysis, patients who were admitted in the last three days of life were more likely to have a hematologic malignancy; were more likely to be male and married; and were younger (age < 65 years). Admission to hospice within three days of death was less likely for those with Medicaid or self-insurance.

"Quality measures of hospice lengths of stay should include patient-mix adjustments for type of cancer and site of care," the authors write.

Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs